GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 118 filers reported holding GENOMIC HEALTH INC in Q4 2013. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $15,860,000 | -45.3% | 548,376 | -51.1% | 0.02% | -51.9% |
Q2 2016 | $29,010,000 | -12.4% | 1,120,296 | -16.2% | 0.05% | -10.3% |
Q1 2016 | $33,118,000 | -34.2% | 1,337,089 | -6.4% | 0.06% | -33.3% |
Q4 2015 | $50,309,000 | +66.4% | 1,429,209 | 0.0% | 0.09% | +47.5% |
Q3 2015 | $30,242,000 | -30.7% | 1,429,209 | -9.0% | 0.06% | -24.4% |
Q2 2015 | $43,641,000 | -24.4% | 1,570,368 | -16.9% | 0.08% | -28.4% |
Q1 2015 | $57,697,000 | -2.3% | 1,888,626 | +2.2% | 0.11% | -7.6% |
Q4 2014 | $59,082,000 | +12.0% | 1,848,047 | -0.9% | 0.12% | +1.7% |
Q3 2014 | $52,775,000 | +38.2% | 1,864,206 | +33.7% | 0.12% | +39.8% |
Q2 2014 | $38,198,000 | +8.4% | 1,394,108 | +4.2% | 0.08% | 0.0% |
Q1 2014 | $35,235,000 | +4.4% | 1,337,715 | +16.0% | 0.08% | +3.8% |
Q4 2013 | $33,750,000 | +32.1% | 1,153,029 | +38.0% | 0.08% | +23.1% |
Q3 2013 | $25,552,000 | +50.4% | 835,566 | +55.9% | 0.06% | +25.0% |
Q2 2013 | $16,993,000 | – | 535,910 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |